home / stock / bngo / bngo quote
Last: | $0.759 |
---|---|
Change Percent: | -2.18% |
Open: | $0.7777 |
Close: | $0.759 |
High: | $0.7841 |
Low: | $0.74 |
Volume: | 833,069 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.759 | $0.7777 | $0.759 | $0.7841 | $0.74 | 833,069 | 04-25-2024 |
$0.7611 | $0.79 | $0.7611 | $0.809899 | $0.756 | 793,773 | 04-24-2024 |
$0.7944 | $0.77 | $0.7944 | $0.81 | $0.77 | 816,611 | 04-23-2024 |
$0.7606 | $0.75 | $0.7606 | $0.79 | $0.74 | 871,068 | 04-22-2024 |
$0.75 | $0.79 | $0.75 | $0.81 | $0.75 | 987,981 | 04-19-2024 |
$0.7872 | $0.8047 | $0.7872 | $0.8199 | $0.7143 | 2,365,348 | 04-18-2024 |
$0.8158 | $0.88 | $0.8158 | $0.885 | $0.7864 | 1,598,564 | 04-17-2024 |
$0.8555 | $0.8801 | $0.8555 | $0.93 | $0.845 | 1,545,198 | 04-16-2024 |
$0.87 | $0.994 | $0.87 | $0.994 | $0.8521 | 3,166,173 | 04-15-2024 |
$0.9775 | $1.01 | $0.9775 | $1.03 | $0.9531 | 1,881,942 | 04-12-2024 |
$1.03 | $1.07 | $1.03 | $1.07 | $1.01 | 861,910 | 04-11-2024 |
$1.04 | $1.04 | $1.04 | $1.07 | $0.99 | 1,819,382 | 04-10-2024 |
$1.05 | $1.06 | $1.05 | $1.11 | $1.04 | 1,141,963 | 04-09-2024 |
$1.06 | $1.04 | $1.06 | $1.08 | $1.02 | 1,081,105 | 04-08-2024 |
$1.02 | $0.9927 | $1.02 | $1.04 | $0.98 | 1,580,921 | 04-05-2024 |
$0.9865 | $1.03 | $0.9865 | $1.16 | $0.9703 | 5,271,769 | 04-04-2024 |
$1.02 | $1 | $1.02 | $1.05 | $0.9976 | 1,026,775 | 04-03-2024 |
$0.9975 | $1.065 | $0.9975 | $1.08 | $0.9601 | 3,206,314 | 04-02-2024 |
$1.07 | $1.135 | $1.07 | $1.14 | $1.01 | 1,573,670 | 04-01-2024 |
$1.11 | $1.1 | $1.11 | $1.17 | $1.09 | 1,718,719 | 03-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
Bionano Genomics Inc. Company Name:
BNGO Stock Symbol:
NASDAQ Market:
Bionano Genomics Inc. Website:
SAN DIEGO, April 24, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced the results of an implementation study conducted by researchers at University Medical Center Groningen that compared optical genome mapping (OGM) to traditional cytogenetic methods for the de...
Bionano, a global leader in the transformation of the cytogenetic workflow with optical genome mapping (OGM), has entered into a strategic partnership with Hangzhou Diagens Biotechnology Co., Ltd. (Diagens), the pioneering leader in artificial intelligence (AI) chromosome karyotype analysis techn...
SAN DIEGO, April 11, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study from Penn State College of Medicine that used optical genome mapping (OGM) to search for clinically and biologically relevant genomic variations in pediatric B-cell ...